Similar articles

• TASC II section F on revascularization in PAD.

  Norgren L, Hiatt WR, Harris KA, Lammer J; TASC II Working Group. Norgren L, et al. J Endovasc Ther. 2007 Oct;14(5):743-4. doi: 10.1177/152660280701400520. J Endovasc Ther. 2007. PMID: 17924742 No abstract available.
• Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment.

  Rabellino M, Zander T, Baldi S, Garcia Nielsen L, Aragon-Sanchez FJ, Zerolo I, Llorens R, Maynar M. Rabellino M, et al. Catheter Cardiovasc Interv. 2009 Apr 1;73(5):701-5. doi: 10.1002/ccd.21971. Catheter Cardiovasc Interv. 2009. PMID: 19309709
• Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.

  Kickuth R, Keo HH, Triller J, Ludwig K, Do DD. Kickuth R, et al. J Vasc Interv Radiol. 2007 Jun;18(6):703-8. doi: 10.1016/j.jvir.2007.03.012. J Vasc Interv Radiol. 2007. PMID: 17538131
• Treating the diseased superficial femoral artery.

  Gibbs JM, Peña CS, Benenati JF. Gibbs JM, et al. Tech Vasc Interv Radiol. 2010 Mar;13(1):37-42. doi: 10.1053/j.tvir.2009.10.005. Tech Vasc Interv Radiol. 2010. PMID: 20123431 Review.
• Current status of lower-extremity revascularization.

  Friedell ML, Stark KR, Kujath SW, Carter RR. Friedell ML, et al. Curr Probl Surg. 2014 Jun;51(6):254-90. doi: 10.1067/j.cpsurg.2014.02.005. Epub 2014 Mar 11. Curr Probl Surg. 2014. PMID: 24863077 Review. No abstract available.